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A B S T R A C T
Studies have indicated that host inflammatory proteins, enzymes and indicators of bone metabolism present in sa-
liva differ in different types of periodontal disease. However, the number of markers analyzed was limited and the ef-
fect of edentulousness was not examined. We measured the concentration of host inflammatory proteins: C-reactive pro-
tein (CRP), C3 and C4 complement components, alpha-2-macroglobulin (-2M) and tumor-necrosis factor (TNF) in
unstimulated saliva of 14 periodontally healthy (PH), 9 edentulous persons (EP), 10 patients with chronic period-
ontitis (CP) and 18 with aggressive periodontitis (AgP). TNF was below the level of detection in all samples except one.
Edentulous persons and patients with CP had significantly reduced concentrations of CRP, C3 and -2M. Edentulous
persons and AgP patients had lower C4 concentrations. We can conclude that edentulous persons and CP patients have
reduced salivary concentrations of host inflammatory proteins. These findings suggest that a reduction in host respon-
siveness might play a role in the pathogenesis of CP.
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Introduction
The diagnostics of periodontal disease relies primar-
ily on clinical and radiographic parameters. These mea-
sures are useful in detecting evidence for past disease,
or verifying periodontal health, but provide limited in-
formation about patients at risk for future periodontal
breakdown1,2.
The gingival crevicular fluid (GCF) is derived from
gingival capillary beds (serum components) and resi-
dent and migrating inflammatory cells. Factors derived
from GCF and the subgingival plaque is found in whole
saliva, rather than gland-specific saliva3.
Saliva can be easily collected, contains locally de-
rived and systemically-derived markers of periodontal
disease, and hence may offer the basis for a patient spe-
cific diagnostic test for periodontitis4. Furthermore, the
analysis of saliva may offer a cost-effective approach to
assess periodontal disease incidence in large popula-
tions1,5.
The use of saliva in periodontal diagnostics has been
the subject of considerable research activity, and pro-
posed markers for disease include proteins of host ori-
gin, phenotypic markers, host cells, hormones, bacteria
and bacterial products, volatile compounds and ions6–8.
Studies have examined enzyme activity in saliva in
relation to periodontal status and in response to perio-
dontal treatment1,4,5,8. Their results indicate that saliva
might contain markers useful for diagnosis of perio-
dontal disease. However, their exact value or the opti-
mal markers combination has not been defined. Also,
the influence of other factors, such as edentulousness,
on saliva constituents has not been analyzed.
We therefore measured following markers of inflam-
mation: C-reactive protein (CRP), C3 and C4 compo-
nents of complement (C3, C4), -2 macroglobulin (-2M)
and tumor necrosis factor (TNF) in whole saliva of pa-
tients with chronic periodontitis (CP), aggressive perio-
dontitis (AgP), periodontal healthy (PH) and edentulous
persons (EP) to identify potential markers useful for di-
agnosis of periodontal disease.
435
Received for publication February 15, 2005
Material and Methods
Subjects
The study included 51 persons, 25 males and 26 fe-
males. Two study groups consisted of 18 untreated AgP
patients, 9 males and 9 females and 10 untreated CP
patients, 5 males and 5 females, refered to our depart-
ment at the Dental School University of Zagreb, for
treatment of periodontal disease. The mean age in the
AgP group was 33 years, ranging from 19–52 years, and
the mean age in the CP group was 38 years, ranging
from 29–49 years. Control group consisted of 14 PH per-
sons, 7 males and 7 females with mean age 24 years,
ranging from 23–25 years, and 9 EP persons, 4 males
and 4 females with mean age of 73 years, ranging from
65–81 years.
Criteria for AgP were: familial history of periodontal
disease, generalized interproximal attachment loss af-
fecting at least 4 permanent teeth other than first mo-
lars and incisors, and radiographically-proven vertical
bone resorption9. Criteria for CP were: gingival inflam-
mation, pocketing with clinical attachment loss of at
least 10 sites with more than 5 mm of clinical attach-
ment loss spread over several teeth and radiographical
evidence of alveolar bone loss of more than 1/3 of the
root length on at least 1 tooth per quadrant10. Perio-
dontal screening was part of initial periodontal exami-
nation, using following clinical measurements: plaque
index (PI)11, sulcus bleeding index (SBI)12, probing depth
and clinical attachment loss (CAL)13. Periodontal tissue
destruction was determined by measuring the attach-
ment level loss calculated from the periodontal probing
depth and gingival retraction. Probing depth was mea-
sured on mesial, distal, oral and vestibular sides of all
teeth while gingival retraction was measured on oral
and vestibular sides of all teeth using a calibrated man-
ual probe. Diseased groups did not differ regarding the
number of teeth.
PH persons were without clinical signs of destruction
of the periodontal ligament, had low plaque and gingival
inflammation levels, and showed no signs of pocketing.
According to anamnestic data reasons for teeth loss
in the EP group were caries and its complications or
periodontal disease.
A dietary and medical history was obtained from all
subjects and all participants received a complete dental
check-up. Individuals were encouraged to follow their
normal daily nutritional regimen; no specific instruc-
tions regarding food or fluid intake were given.
Exclusion criteria were: individuals who had serious
systemic diseases, such as diabetes or cancer, smoking
(including persons who stopped smoking less than 2 yrs.
ago) extensive carious lesions, medication in the 6
months preceding the study (e.g. immunosuppressive
drugs, antibiotics, antiphlogistics) or pregnancy.
After the purpose and scope of the study was ex-
plained to them, all subjects gave an written informed
consent for participation in this study.
Approval for this investigation was given by the Eth-
ical Committee.
Collection of saliva
All saliva samples were collected in the morning, at
least 2 hours after any food intake. Unstimulated saliva
was collected after oral cavity irrigation with water. Af-
ter the irrigation, the subjects took 5 ml of water and
held it for 5 minutes in oral cavity, after which the sam-
ple was taken. Unstimulated saliva was obtained by
passive drooling during 10 min with the subjects sitting
in a relaxed position. About 4–5 ml of saliva was placed
in an ice chilled test tube and transported to the Depart-
ment of Laboratory Diagnostics, University Hospital
Center Zagreb. All samples were homogenized, stored at
–70°C and tested simultaneously.
To determine the temporal variability of tested sali-
vary substances in 5 patients with AgP and 5 with CP,
samples were obtained 3 times during a period of 1 h.
Furthermore, the concentration of tested substances
was determined in the same subjects on a standard diet
for 3 consecutive days.
Laboratory methods
CRP concentrations were determined by simple ra-
dial immunodiffusion, using specific anti-human CRP
antibodies forming insoluble aggregates after binding
(intra assay CV%=1.02, inter-assay CV%=1.29)14. C3
and C4 were determined photometrically after radial im-
munodiffusion on LC-Partingen plates (Behring, Frank-
furt, Germany), based on formation of immune com-
plexes with specific antibodies (intra-assay CV% = 1.9,
1.8; inter-assay CV%=5.9, 2.9 for C3 and C4 respec-
tively)15. -2M concentrations were determined using
the same method (intra-assay CV%=1.6, inter-assay
CV%=3.0)15. TNF was determined employing linked
immunosorbent assay ELISA with specific monoclonal
antibodies (Endogen, Cambridge, Ma, USA) (inter-as-
say CV%=1.6, intra-assay CV%=3.3)14.
Statistical analyses
Differences between groups for tested variables were
assessed using variance analysis, and for clinical at-
tachment loss using t-test. Normality of distribution
was tested with Kolmogorov-Smirnov test. The correla-
tion of variables was tested with Pearson correlation co-
efficient.
Results
Sex did not influence the finding. The mean CAL
level in CP patients was 3.4 mm, range 1.8–4.7 mm, and
in AgP patients 4.2 mm, range 3.0–6.4 mm. This differ-
ence was not significant (p=0.07). Maximal attachment
loss (CALMAX) is different in CP and AgP groups. In
the CP group CALMAX was 5.4 mm, range 2.8–9.0 mm.
In the AgP group CALMAX was 6.7 mm, range 4.8–9.5
mm (Table 1).
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The mean PI for the CP group was 0.8, and 1.9 for
the AgP group. Mean SBI scores were 1.26 in CP pa-
tients and 3.02 in AgP patients. In the PH group mean
PI was 0.6, mean SBI score was 0.5 and mean CAL 0.3
mm, range 0–0.8 mm.
TNF was below the level of detection in all samples
except one from a patient with AgP.
Table 1 shows mean values and standard deviations
(SD) of variables: CRP, C3, C4 and -2M. The groups
differ in proinflammatory marker concentrations observ-
ed in unstimulated saliva. CRP values in saliva were
highest in the AgP group (102.11±79.02), then in the PH
group (90.20±79.67), while CP and EP groups show sig-
nificantly lower values (27.45±29.59) and (20.72±29.51).
Observing the paired-differences significant difference
exists in CRP concentrations between EP and AgP, and
CP and AgP groups.
Tested groups show similar relationship when C3
concentrations are analysed. Similarly high values are
observed in PH and AgP groups (10.74±8.03 and 10.39±
5.08), while EP and CP groups show almost three times
lower C3 concentrations in saliva (3.79±2.25 and 3.62±
2.94). The differences between pairwise PH and EP, PH
and CP, AgP and EP, and AgP and CP groups are statis-
tically significant.
The highest C4 concentration was observed in the
PH group (35.36±11.74), somewhat lower in CP group
(24.10±10.67). For AgP group C4 concentration was
20.55±7.82, and EP group showed lowest concentrations
C4 in saliva (17.50±12.84). Statistically significant dif-
ferences in C4 concentrations were found between fol-
lowing pairs: PH and EP, PH and CP, EP and AgP, and
CP and AgP.
When differences in -2M concentrations in the sa-
liva are analysed between the groups, they show rela-
tion similar to differences of CRP and C3 values be-
tween the groups. Mean concentration of -2M in saliva
of PH group is 401.14±484.58, and 384.57±383.48 in the
AgP group. In the EP and CP group -2M concentra-
tions were approximately seven times lower (57.00±
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TABLE 1
VARIABLES FOR MARKERS OF PERIODONTAL DISEASE IN SALIVA AND ATTACHMENT LOSS FOR CP AND AGP GROUPS
Variables Groups N X SD Standard error Test statistics df p
CRP PH 14 90.20 79.67 21.29
4.95a 3, 47 0.005
EP 18 20.72 29.51 9.84
CP 10 27.45 29.59 9.36
AgP 9 102.11 79.02 18.62
Total 51 69.84 73.18 10.25
C3 PH 14 10.74 8.03 2.15
6.15a 3, 47 0.001
EP 18 3.79 2.95 0.98
CP 10 3.62 2.94 0.93
AgP 9 10.39 5.08 1.20
Total 51 8.00 6.30 0.88
C4 PH 14 35.36 11.74 3.14
7.18a 3, 47 <0.001
EP 18 17.50 12.84 4.28
CP 10 24.10 10.67 3.37
AgP 9 20.55 7.82 1.84
Total 51 24.77 12.29 1.72
-2M PH 14 401.14 484.58 129.51
3.74a 3, 47 0.017
EP 18 57.00 42.25 14.08
CP 10 58.70 42.97 13.59
AgP 9 384.57 383.48 90.39
Total 51 267.42 371.89 52.07
CAL CP 10 3.40 0.89 0.28
–1.89b 26 0.070AgP 18 4.18 1.12 0.26
Total 28 3.91 1.09 0.21
CALMAX CP 10 5.40 1.80 0.57
–2.03b 26 0.050AgP 18 6.69 1.49 0.35
Total 28 6.23 1.69 0.32
aF-test, bt-test, CP – chronic periodontitis, AgP – aggressive periodontitis, PH – periodontally healthy, EP – edentulous persons, CAL
– mean clinical attachment loss,CALMAX – maximal clinical attachment loss, CRP – C-reactive protein, -2M – -2 macroglobulin,
C3 – C3 complement component, C4 – C4 complement component
42.25, and 58.70±42.97). Statistically significant differ-
ences in the -2M concentrations were found pairwise
between PH and EP, CP and AgP, and EP and CP.
Correlation between the tested variables (CRP, C3,
C4 and -2M) was tested using Pearson correlation coef-
ficient. In the PH group significant positive correlation
was observed between -2M and CRP (r=0.703, p=0.005).
Significant positive correlation was also observed be-
tween -2M and CRP (r=0.922, p<0.001).
Between immunological and clinical variables, there
was no significant correlation in the CP group (Table 2).
Similarly, no correlation was observed in the AgP group
between immunological and clinical variables (Table 3).
Discussion
Our data show that patients with different types of
periodontitis differ between themselves and from he-
althy persons in their salivary content of inflammatory
or bone destruction markers. This supports the hypoth-
esis that biochemical analyses of saliva might be an im-
portant non-invasive way of studying disease processes
in periodontitis16. However, since teeth loss exerts a
very strong influence on these variables, future studies
must take this factor into account. TNF concentration in
saliva is below the level of detection of commercially
available assays and investigators who wish to measure
it should use alternative methods.
CRP, C3 and -2M are humoral inflammatory mark-
ers and acute phase reactants. Reduced levels of these
proteins in saliva of patients with CP, indicates that in
this chronic disorder host inflammatory response is
reduced17–20. C4 is also a humoral inflammatory marker
and acute phase reactant. In contrast to C4, C3 and
-2M is higher in AgP in comparison to CP patients or
PH group. Reduced concentrations of these proteins and
C4 in EP group can be explained by the lack of gingival
fluid component in their saliva.
In summary, our data show that the measurement of
host inflammatory markers in the saliva might be a
valuable path to follow in studying periodontal health
and disease, taking into account that teeth loss pro-
foundly affects these findings. CP is characterized by a
reduction in concentrations of different inflammatory
markers, indicating that a reduced host response might
be important in the pathogenesis of this disorder21.
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TABLE 2
CORRELATION OF VARIABLES FOR CP GROUP (N=10)
Variables CRP C3 C4 -2M CAL CALMAX
CRP – 0.903* –0.031 0.326 –0.327 –0.229
C3 0.903* – 0.118 0.092 –0.205 –0.224
C4 –0.031 0.118 – 0.021 0.010 –0.333
-2M 0.326 0.092 0.021 – 0.082 –0.010
CAL –0.327 –0.205 0.010 0.082 – 0.890*
CALMAX –0.229 –0.224 –0.333 –0.010 0.890* –
*correlation is significant at the 0.01 level, CP – chronic periodontitis, CAL – mean clinical attachment loss, CALMAX – maximal
clinical attachment loss, CRP – C-reactive protein, -2M – -2 macroglobulin, C3 – C3 complement component, C4 – C4 complement
component
TABLE 3
CORRELATION OF VARIABLES FOR AGP GROUP (N=18)
Variables CRP C3 C4 -2M CAL CALMAX
CRP – 0.387 –0.132 0.384 0.123 0.245
C3 0.387 – –0.090 0.000 –0.257 –0.297
C4 –0.132 –0.090 – 0.222 –0.035 0.063
-2M 0.384 0.000 0.222 – 0.023 0.183
CAL 0.123 –0.257 –0.035 0.023 – 0.917*
CALMAX 0.245 –0.297 0.063 0.183 0.917* –
*correlation is significant at the 0.01 level, AgP – aggressive periodontitis, CAL – mean clinical attachment loss, CALMAX – maxi-
mal clinical attachment loss, CRP – C-reactive protein, -2M – -2 macroglobulin, C3 – C3 complement component, C4 – C4 comple-
ment component
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FAKTORI UPALE U SLINI KAO MOGU]I BILJEZI PARODONTNE BOLESTI
S A @ E T A K
Slina ~ini pogodan medij za otkrivanje proupalnih biljega u usnoj {upljini. Brojni serumski i tkivni sastojci koji
prolaze kroz stijenku spojnog epitela gingivnog sulkusa i ulaze u slinu, mogu pomo}i u odre|ivanju aktivnosti paro-
dontitisa. Stoga smo istra`ivali me|uzavisnost medijatora lokalne imunosti u slini doma}ina i klini~ke parametre
destrukcije u oboljelih od kroni~nog (CP) i agresivnog (AgP) parodontitisa. Koncentraciju upalnih proteina doma}ina
odre|ivali smo enzim-imunokemijskim testovima i u slini bezubih (E), {to do sada nije istra`ivano, te u parodont
zdravih osoba (PH). Stupanj destrukcije parodonta mjeren je gubitkom vezivnog pri~vrstka (CAL). Istra`ivanje je
obuhvatilo 51 osobu. Struktura navedenih uzoraka i njihova me|uzavisnost testirana je neparametrijskim meto-
dama. Dobiveni rezultati pokazuju kako se razina C-reaktivnog proteina (CRP), C3-komponente komplementa (C3),
-2 makroglobulina zna~ajno razlikuju u nativnoj slini oboljelih od CP i AgP. Bezube osobe, sli~no CP skupini, poka-
zivale su zna~ajnu redukciju koncentracije CRP, C3 i -2M. C4 komponenta komplementa ne mjeri razliku me|u
bolesnima. Zaklju~iti se mo`e kako se razina medijatora obrane doma}ina razlikuje za pojedine vrste parodontitisa u
nativnoj slini.
